Abbott Laboratories vs. Rallybio Corporation Common Stock
Abbott Laboratories and Rallybio Corporation Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | RLYB | |
|---|---|---|
| Market Cap | $170.43 billion | $90.26 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | RLYB | |
|---|---|---|
| Dividend Yield | 2.53% | — |
ABT and RLYB split the dividend factors evenly.
Risk & Sentiment
| ABT | RLYB | |
|---|---|---|
| Short Interest | 0.57% | 0.02% |
RLYB leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, RLYB overview, RLYB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.